Loading...

Eurofins Scientific SE

ERFSFPNK
Healthcare
Medical - Diagnostics & Research
$71.01
$-2.78(-3.77%)

Eurofins Scientific SE (ERFSF) Stock Overview

Explore Eurofins Scientific SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.6/100

Key Financials

Market Cap12.5B
P/E Ratio35.00
EPS (TTM)$2.40
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$67.41
1 Month$56.98
3 Months$55.73
1 Year Target$50.61

ERFSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Eurofins Scientific SE (ERFSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $50.61.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.00 and a market capitalization of 12.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
6.70%
6.70%
Profit Growth
$1.72
30.97%
EPS Growth
$1.72
32.30%
Operating Margin
14.56%
100.00%
ROE
7.17%
30.97%
Dividend Yield
0.00%
49.58%

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0

Price Targets

Low$0.00
Average$0.00
High$0.00

Company Profile

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

CEO

Gilles G. Martin

Employees

62,696

Headquarters

23 Val Fleuri, Luxembourg City

Founded

2010

Frequently Asked Questions

;